BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12000106)

  • 1. The National DES Education Program: effectiveness of the California Health Provider Intervention.
    Cohn BA; Wingard DL; Patterson RC; McPhee SJ; Gerbert B
    J Cancer Educ; 2002; 17(1):40-5. PubMed ID: 12000106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals.
    Hammes B; Laitman CJ
    J Midwifery Womens Health; 2003; 48(1):19-29. PubMed ID: 12589302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DES update. Research still underway.
    Mayo Clin Womens Healthsource; 2004 Mar; 8(3):6. PubMed ID: 15001850
    [No Abstract]   [Full Text] [Related]  

  • 5. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
    Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
    Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age at natural menopause in women exposed to diethylstilbestrol in utero.
    Hatch EE; Troisi R; Wise LA; Hyer M; Palmer JR; Titus-Ernstoff L; Strohsnitter W; Kaufman R; Adam E; Noller KL; Herbst AL; Robboy S; Hartge P; Hoover RN
    Am J Epidemiol; 2006 Oct; 164(7):682-8. PubMed ID: 16887893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES).
    Herbst AL
    Gynecol Oncol; 2000 Feb; 76(2):147-56. PubMed ID: 10637063
    [No Abstract]   [Full Text] [Related]  

  • 8. DES exposure and the aging woman: mothers and daughters.
    Laitman CJ
    Curr Womens Health Rep; 2002 Oct; 2(5):390-3. PubMed ID: 12215312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and management of DES-exposed women.
    Vieiralves-Wiltgen C; Engle VF
    Nurse Pract; 1988 Nov; 13(11):15-6, 19-20, 22 passim. PubMed ID: 3231355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
    Edelman DA
    Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to a xenoestrogen before birth: the diethylstilbestrol experience.
    Palmlund I
    J Psychosom Obstet Gynaecol; 1996 Jun; 17(2):71-84. PubMed ID: 8819018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
    Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
    J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium.
    Larson PS; Ungarelli RA; de Las Morenas A; Cupples LA; Rowlings K; Palmer JR; Rosenberg CL
    Cancer; 2006 Nov; 107(9):2122-6. PubMed ID: 16998936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hypospadias in grandsons of women exposed to diethylstilbestrol during pregnancy: a multigenerational national cohort study.
    Kalfa N; Paris F; Soyer-Gobillard MO; Daures JP; Sultan C
    Fertil Steril; 2011 Jun; 95(8):2574-7. PubMed ID: 21458804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971.
    Herbst AL; Ulfelder H; Poskanzer DC; Longo LD
    Am J Obstet Gynecol; 1999 Dec; 181(6):1574-5. PubMed ID: 10601946
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
    Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
    Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine exposure to diethylstilbestrol: long-term effects in humans.
    Swan SH
    APMIS; 2000 Dec; 108(12):793-804. PubMed ID: 11252812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician advisory: health effects of the pregnancy use of diethylstilbestrol.
    Richmond JB
    Clin Toxicol; 1979 Mar; 14(3):313-8. PubMed ID: 37020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital clear cell adenocarcinoma.
    Johnston GA; Jones HA
    Int Surg; 1983; 68(3):257-61. PubMed ID: 6662641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.